<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20140907019082N12</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-11-25</date_registration>
      <primary_sponsor>Tabriz University of Medical Sciences</primary_sponsor>
      <public_title>Effect of weight self-stigma reduction intervention on obesity treatment</public_title>
      <acronym></acronym>
      <scientific_title>Comparison of the effectiveness of low-calorie diet alone and in combination with cognitive-behavioural therapy intervention to reduce weight self-stigma on diet adherence and anthropometric indices in adult women with obesity and weight self-stigma: a randomized clinical trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-08-17</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>120</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/71348</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Education/Guidance, Randomization description: Individuals will be included in the study through availability sampling from the nutrition and diet therapy clinic and will be divided into intervention and control groups using simple randomization and will be matched based on age, BMI, and the use of supplements or drugs.
In this study, we will use block randomization. The size of all the blocks is the same and we will have blocks of size 4 in this two-group experiment. For randomization, www.sealedenvelope.com website is used, which can generate random sequences in addition to simple randomization by blocking method. For concealment, we use allocation concealment, which is the method used to execute a random sequence on study participants, so that the assigned group is not known before the individual is assigned. Using opaque envelopes sealed with a random sequence (Sequentially numbered, sealed, opaque envelopes) in which in this method each random sequence is recorded on a card and the cards are placed in the envelopes respectively. In order to maintain a random sequence, the envelopes are numbered in the same way on the outer surface. Finally, the lids of the envelopes are glued and placed inside a box, respectively. At the beginning of the registration of participants, based on the order of entry of eligible participants into the study, one of the envelopes is opened in order and the assigned group of the participant is revealed.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Condition 1: obesity. Condition 2: weight self-stigma.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: providing a monthly weight-loss diet in the form of a 30% reduction of the total daily caloric requirement calculated by the Mifflin st jeor formula (minimum calorie prescribed diet is 1200 kcal) and with the ratio of macronutrients in the form of 15-18% protein, 50-53% carbohydrates and 30-32% fat, along with the provision of cognitive-behavioral intervention to reduce self-stigma by a psychologist in the form of weekly group therapy sessions, using PowerPoint, for 12 weeks with CBT technique, providing a summary of the group therapy sessions in the form of a pamphlet at the end of each session and providing the content of the group therapy sessions through a phone call to absentees. Intervention 2: Control group: receiving only the weight-loss diet as the same of intervention group.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is not planned yet</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Mahdieh Abbasalizad Farhangi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz University of Medical Sciences, Attar Neishaboory St.</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614711</zip>
        <telephone>+98 413357580</telephone>
        <email>abbasalizadm@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Mahdieh Abbasalizad Farhangi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Tabriz University of Medical Sciences, Attar Neishaboory St.</address>
        <city>Tabriz</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>5166614711</zip>
        <telephone>+98 413357580</telephone>
        <email>abbasalizadm@tbzmed.ac.ir</email>
        <affiliation>Tabriz University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Willingness to participate in the study and sign a written consent form
Age between 18 and 50 years
Body mass index (BMI) between 30 and 40 Kg/m2
Confirmation of weight self-stigma by questionnaire</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>50 years</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Suffering from certain diseases or a serious condition (such as bulimia) that affects the results of the study
Receive specialized psychological counseling to treat weight self-stigma in the last 3 months</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>E66</hc_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Overweight and obesity</hc_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Behavior</i_code>
      <i_code>Treatment - Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: providing a monthly weight-loss diet in the form of a 30% reduction of the total daily caloric requirement calculated by the Mifflin st jeor formula (minimum calorie prescribed diet is 1200 kcal) and with the ratio of macronutrients in the form of 15-18% protein, 50-53% carbohydrates and 30-32% fat, along with the provision of cognitive-behavioral intervention to reduce self-stigma by a psychologist in the form of weekly group therapy sessions, using PowerPoint, for 12 weeks with CBT technique, providing a summary of the group therapy sessions in the form of a pamphlet at the end of each session and providing the content of the group therapy sessions through a phone call to absentees.</i_keyword>
      <i_keyword>Control group: receiving only the weight-loss diet as the same of intervention group</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Weight self-stigma score using WBIS questionnaire. Timepoint: assessment of weight self-stigma score at the beginning, day 30, 60 and 120 of the study. Method of measurement: assessment of weight self-stigma score with the Weight Bias Internalization Scale (WBIS) questionnaire.</prim_outcome>
      <prim_outcome>Adherence percentage to weight loss diet. Timepoint: Measuring percentage of adherence to weight loss diet at the beginning, day 30, 60 and 120 of the study. Method of measurement: Measuring the percentage of adherence to the weight loss diet using the method of Pedro et al. (2009).</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>General mental health. Timepoint: At the beginning, on the 30th, 60th and 120th day of the study. Method of measurement: GHQ-28 questionnaire.</sec_outcome>
      <sec_outcome>The intake of energy, micronutrients and macronutrients. Timepoint: At the beginning, on the 30th, 60th and 120th day of the study. Method of measurement: FFQ questionnaire and 3-day food record.</sec_outcome>
      <sec_outcome>Weight. Timepoint: At the beginning, on the 30th, 60th and 120th day of the study. Method of measurement: With the InBody 230 device.</sec_outcome>
      <sec_outcome>Height. Timepoint: At the beginning of the study. Method of measurement: seca stadiometer.</sec_outcome>
      <sec_outcome>Waist circumference. Timepoint: At the beginning, on the 30th, 60th and 120th day of the study. Method of measurement: tape measure.</sec_outcome>
      <sec_outcome>Hip circumference. Timepoint: At the beginning, on the 30th, 60th and 120th day of the study. Method of measurement: tape measure.</sec_outcome>
      <sec_outcome>Fat mass. Timepoint: At the beginning, on the 30th, 60th and 120th day of the study. Method of measurement: With the InBody 230 device.</sec_outcome>
      <sec_outcome>Fat-free mass. Timepoint: At the beginning, on the 30th, 60th and 120th day of the study. Method of measurement: With the InBody 230 device.</sec_outcome>
      <sec_outcome>Body water. Timepoint: At the beginning, on the 30th, 60th and 120th day of the study. Method of measurement: With the InBody 230 device.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Tabriz University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-10-02</approval_date>
        <contact_name>ٍEthics committee of Nutrition Faculty, Tabriz University of Medical Sciences</contact_name>
        <contact_address>Nutrition Faculty, Tabriz University of Medical Sciences, Attar Street, Golgasht Street, Tabriz Tabriz East Azarbaijan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
